Low-Dose CT Screening with Guidance from Biomarkers May be Beneficial for Some Patients Who Have Never Smoked
Beth Fand IncollingoAlthough about 20% of those who die of lung cancer in the United States each year have never smoked,1 only individuals with heavy smoking histories are eligible for low-dose CT […] Read more
Strategies for Implementing Lung Cancer Screening Programs in Low-Middle Income Countries
Kara Nyberg, PhDA wide range of nations at various stages of economic and health-system development fall under the umbrella of low- and middle-income countries (LIMC). As Lucía Viola, MD, of the Fundación […] Read more
Low-Dose CT Could be One-Stop Test for Early Signs of China’s ‘Big Three’ Chest Diseases
Finding one effective test for the three chest conditions that are the leading causes of death in China, without a high risk of false positives, would allow better control of […] Read more
The first forays into lung cancer screening began in the 1970s, with two trials evaluating the use of chest x-ray and sputum cytology to detect disease. Those trials showed no […] Read more
Even the most advanced CT scanners available face limitations in their ability to measure small lung nodules. This is a concern since small errors in two-dimensional measures can quickly balloon […] Read more
IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies
Joy CurzioAlthough clinical trials are vitally important to researchers working to improve therapies for lung cancer, clinical trials also provide what could be lifesaving treatments to those patients on trials. When […] Read more
Advancing Combined Modality Therapy for Early-Stage, Screen-Detected Disease: Adjuvant/Neoadjuvant Therapy
David Yankelevitz, MD+more
During the 17th annual Quantitative Imaging Workshop held in late Fall 2020, the Initiative for Early Lung Cancer Research on Treatment (IELCART) offered two sessions with panel discussions exploring the […] Read more
Differences in Smoking and Lung Cancer Incidence Among Black and White Young Adults in the United States
Robin Cornelissen, MD, PhDIn the United States, racial disparities in lung cancer incidence are known to exist. This is most likely caused by higher smoking prevalence among non-Hispanic Black adults compared to non-Hispanic […] Read more
Prolonging CT Screening Intervals is Deemed Safe in Individuals with Negative Baseline Results
In his May 7 presentation “Advance Lung Cancer Screening Globally,” Dr. Pastorino, co-chair of the CT Screening Symposium and director of the Thoracic Surgery Division at the Istituto Nazionale Tumori in Milan, discussed the MILD, BioMILD, and SMILE trials. He also is chair of the IASLC’s Screening and... Read more
Gouri Shankar Bhattacharyya, MD, FRCP, died this past week of COVID-19–related complications. A medical oncologist in Kolkata, India, with 25 years of experience, Dr. Bhattacharyya’s special interests were many and […] Read more